Interview with CEO Angelo Stracquatanio Part 2
- Published:Dec 27, 2024
- ●
- Category:Industry Perspective
We are excited to share Part 2 of our interview with Apprentice.io CEO Angelo Stracquatanio, where we dive deep into the revolutionary AI capabilities of the Tempo Manufacturing Cloud platform that are transforming pharmaceutical manufacturing. Apprentice is thoughtfully integrating AI into pharmaceutical manufacturing - not just as a chatbot, but as a comprehensive suite of intelligent tools embedded throughout the manufacturing process.
Some of our Key AI innovations we cover include: auto-converting paper/PDF procedures and batch records into digital workflows; transforming Legacy MES XML exports into modern digital procedures with automated formula and logic transfer; AI-powered simulations to validate procedures before deployment, dramatically reducing UAT time; intelligent co-pilot and additional AI tools to help review and release batches faster.
"It needs to solve legitimate problems for the industry." That's why we've embedded AI capabilities throughout the entire manufacturing process, from initial recipe creation to final batch release.," Angelo Stracquatanio, CEO & Co-founder, Apprentice.io
Looking ahead, early 2025 will bring groundbreaking Agentic AI capabilities that go beyond current generative AI tools with a focus on a "human-in-the-loop" approach ensuring AI makes recommendations but humans make final GMP decisions. We will also be building towards a future where AI enables instant release for personalized medicines.The message is clear: These transformative AI capabilities are only available if you digitize.